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Background: Obesity and hypertension are associated with increased leptin production
contributing to cardiovascular remodeling. Mechanisms involving mechanical stretch-
induced leptin production and the cross talk between signaling pathways leading to
vascular remodeling have not been fully elucidated.
Methods and Results: Rat portal vein (RPV) organ culture was used to investigate the
effect of mechanical stretch on leptin protein expression in vascular smooth muscle cells
(VSMCs). Moreover, the involvement of reactive oxygen species (ROS), the RhoA/ROCK
pathway, actin cytoskeleton dynamics and the transcriptional factor GATA-4 activation
in mechanical stretch-induced vascular remodeling were investigated. Stretching the
RPV for 1 or 24 h significantly increased leptin protein level and ROS formation in
VSMCs, which was prevented by 1 h pretreatment with the ROCK inhibitor Y-27632
and the actin cytoskeleton depolymerization agent cytochalasin D. Moreover, Western
blotting and immunohistochemistry revealed that mechanical stretch or treatment with
3.1 nmol/L leptin for 24 h significantly increased actin polymerization, as reflected by
an increase in the F-actin to G-actin ratio. Increases in blood vessels’ wet weight
and [3H]-leucine incorporation following a 24 h treatment with conditioned media from
cultured stretched RPVs indicated RPV hypertrophy. This effect was prevented by
1 h pretreatment with anti-leptin antibody, indicating leptin’s crucial role in promoting
VSMC hypertrophy. As an index of GATA-4 activation, GATA-4 nuclear translocation
was assessed by immunohistochemistry method. Pretreating VSMC with leptin for 1 h
significantly activated GATA-4 nuclear translocation, which was potently attenuated by
the NADPH oxidase inhibitor apocynin, Y-27632, and cytochalasin D.
Conclusion: Our results demonstrate that ROS formation, RhoA/ROCK pathway, and
GATA-4 activation play a pivotal role in mechanical stretch-induced leptin synthesis
leading to VSMC remodeling.
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INTRODUCTION
The cardiovascular system is constantly exposed to mechanical
stress due to blood pressure. An increase in blood pressure
(hypertension) leads to vascular and cardiac remodeling
(Zeidan et al., 2003b, 2007; Zhang et al., 2005; Kai et al., 2009).
Hypertension, regardless of its underlying cause, is a major
risk factor for other cardiovascular diseases, such as vascular
hypertrophy, left ventricular hypertrophy, and heart failure
(Zeidan et al., 2003b; Zhang et al., 2005). Different signaling
pathways are involved in hypertension-induced vascular
remodeling (Zeidan et al., 2003b; Zhang et al., 2005) such as
the RhoA/ROCK pathway which results in an increased in
actin polymerization and depletion in G-actin (Zeidan et al.,
2007). Under normal physiological conditions, the ratio of
F-actin to G-actin is low, thus attenuating the activity of the
transcription factor SRF and down-regulating hypertrophic gene
expression (Nelson et al., 2005; Zeidan et al., 2006). However,
activation of the RhoA/ROCK pathway increases F-actin to
G-actin ratio and as a result, promotes vascular remodeling
and hypertrophy. PI3K/AKT pathway is another pathway that
is involved in the changes in actin cytoskeleton dynamics
via LIMK/cofilin phosphorylation (Zeidan et al., 2007). Thus
there is a cross-talk between the PI3K/AKT and RhoA/ROCK
pathways in promoting vascular hypertrophy (Li et al., 2009; Fan
et al., 2014). The activation of the MAP kinases ERK1/2 and
p38 is also another essential pathway involved in mechanical
stretch-induced VSMC hypertrophy (Zeidan et al., 2000).
Hypertension is associated with high levels of the obesity-
associated protein leptin (hyperleptinemia; Agata et al., 1997;
Uckaya et al., 1999). In addition, we have previously shown that
mechanical stretch, which mimics hypertension, enhances the
release of leptin from vascular smooth muscle cells (VSMCs;
Zeidan et al., 2005). Leptin is a 16 kDa protein that is best known
for its function as a satiety factor. It circulates in the blood of lean
individuals at levels between 5 and 15 ng/mL (Sinha et al., 1996).
These levels are higher in obese individuals and may reach up
to 50 ng/mL, due to a higher adipose tissue mass (Sinha et al.,
1996). In addition to adipocytes, leptin is produced by other
kinds of cells including cardiomyocytes and VSMCs (Zeidan
et al., 2005; Matsui et al., 2007). Different studies have shown that
the functional leptin receptor, leptin receptor b (OBRb), is found
in a variety of cells such as VSMCs (Zeidan et al., 2005; Zeidan
and Karmazyn, 2006), cardiomyocytes (Rajapurohitam et al.,
2003), myometrial cells (Markowska et al., 2005), endothelial cells
(Mutze et al., 2006), and T-lymphocytic cells (Martin-Romero
et al., 2000; Lord et al., 2002). Therefore, this hormone has a wide
range of pleiotropic effects and affects the cardiovascular, nervous,
reproductive, and immune systems (Lord et al., 1998; Margetic
et al., 2002; Rahmouni and Haynes, 2004). Leptin promotes
hypertension, vascular remodeling, sympathetic nervous system
stimulation, ROS generation, angiogenesis, and atherosclerosis
(reviewed, by Ghantous et al., 2015). Hence, leptin potentially
contributes to many cardiovascular risks associated with
obesity.
Blood vessels exposed to hypertension generate excessive
levels of reactive oxygen species (ROS; Paravicini and Touyz,
2006, 2008; Montezano and Touyz, 2012). The main source of
cardiovascular ROS is a family of NADPH oxidases (Nox), such
as Nox1, Nox2, Nox4, and Nox5 (Montezano and Touyz, 2012).
Under stressful environmental conditions like hypertension, ROS
levels increase in a phenomenon known as oxidative stress
(Montezano and Touyz, 2012). ROS-mediated endothelial cell
and VSMC damage promotes remodeling of the vasculature
and atherosclerosis (Touyz and Schiffrin, 2004; Mei et al.,
2015).
The transcription factor GATA-4 has been studied in the
cardiac system to promote hypertrophy by translocating to the
nucleus and activating hypertrophic gene expression, such as
b-MHC, c-fos, c-jun, c-myc, BNP, and ANF (Chien et al.,
1991; Liang and Gardner, 1999; Saadane et al., 1999; Babu
et al., 2000; Hsieh et al., 2015). For example, GATA-4 has been
shown to modulate the transcriptional activation of angiotensin
II type1A receptor and b-MHC in pressure overload-induced
cardiac hypertrophy (Herzig et al., 1997; Oka et al., 2006).
GATA-4 also interacts with NFAT3, another transcription factor
that is involved in promoting cardiac hypertrophy (Molkentin
et al., 1998). Thus, GATA-4 has been well characterized in
the cardiac system in promoting hypertrophy; however, the
present knowledge of the role it plays in the vascular system
has been limited to regulating cardiac angiogenesis (Heineke
et al., 2007) and embryonic angiogenesis in the vascular plexus
(Torregroza et al., 2012). Since GATA-4 is well known to promote
cardiac hypertrophy, it is interesting to study whether leptin-
induced vascular remodeling could be mediated by GATA-
4, thus discovering a new role for GATA-4 in the vascular
system.
The mechanisms by which hypertension/leptin or ROS
induce vascular hypertrophy have not been fully elucidated
yet. Accordingly, the present study was designed to determine
the interaction between hypertension, leptin, and ROS and
to identify their role in promoting vascular hypertrophy.
In addition, the involvement of the RhoA/ROCK pathway
and actin cytoskeleton remodeling in hypertension/leptin-
induced ROS formation and vascular hypertrophy were
investigated in this study. The transcriptional factor GATA-
4 nuclear translocation was also examined in order to
take a detailed look at the mechanism promoting VSMC
hypertrophy.
To achieve these aims, rat portal vein (RPV) organ culture
was used. This blood vessel is a large vessel that is both pre-
and post-capillary and has spontaneous myogenic tone (Sutter,
1990; Zeidan et al., 2000). Being a low-pressure vessel, it
is very sensitive to pressure increase (Malmqvist and Arner,
1988, 1990). Moreover, the RPV has been extensively used
as an analog of small pre-capillary resistance vessels (Ljung,
1990; Sutter, 1990). Morphologically, the portal vein has a thin
inner circular layer of VSMCs and a thick, very pronounced
longitudinal layer of VSMCs (Sutter, 1990). The longitudinal
orientation of the VSMCs provides an in vitro model to mimic
hypertension by mechanically stretching it using weights that
stretch the vein equivalently to the in vivo force of stretch exerted
on blood vessels in hypertension (see Rat Portal Vein Organ
Culture).
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MATERIALS AND METHODS
Rat Portal Vein Organ Culture
Male Sprague-Dawley rats (200–250 g) were killed by CO2, as
approved by the Animal Ethics Committee, American University
of Beirut. The investigation conforms to the Guide for the Care
and Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85–23, revised 2011).
RPVs were dissected in a sterile environment and cleaned in
N-Hepes buffer solution (400 mM NaCl, 200 mM KCl, 100 mM
MgCl2, 100 mM Hepes, 11.5 mM Glucose, 5% penicillin-
streptomycin). RPVs were cut longitudinally resulting in two
equal portal vein strips and weighed when needed. Silver weights
of 0.6 g (stretch the blood RPV slightly above optimal length or
10% stretch) were tied to the end of the strip on which stretch
studies were to be performed. The other strip was left unstretched
and used as a control. In cases where an entire vein was needed,
weights of 1.2 g were used. The strips were then transferred
to culture media of DMEM/F-12 HAM with 5% penicillin/
streptomycin). RPVs were incubated at 37°C and 5% CO2 in air.
When leptin (Rat Leptin, Biovision, San Francisco, USA) was
used as treatment, a concentration of 3.1 nmol/L was added.
Inhibitors such as the selective ROCK inhibitor Y-
27632 (10 mmol/L, Sigma Aldrich, MO, USA), the actin
depolymerization agent cytochalasin D (1 mmol/L; Calbiochem,
CA, USA), the NADPH oxidase inhibitor apocynin (1 mmol/L,
4-Hydroxy-3-methoxyacetophenone, Sigma Aldrich, MO, USA),
and the anti-leptin antibody Ob (Y-20) (1 mmol/L; Santa Cruz
Biotechnology, CA, USA) were added to the media 60 min before
mechanically stretching the RPV or adding leptin. Following
incubation, the RPV strips were taken out of the incubator and
either weighed (Zeidan et al., 2000) or immediately frozen in
liquid nitrogen and stored at 80°C for protein analysis.
When conditioned media (CM) was used, RPVs were cultured
in DMEM F-12 HAM either unstretched or stretched for 24 h.
Media was then centrifuged at 800  g for 10 min, followed by
centrifugation at 5000 RPM for 15 min with a Centricon Plus-20
filter (Millipore Corporation,MA, USA) to concentrate themedia
100-fold and yield concentrated CM.
Immunoblotting
Rat portal veins were homogenized in 100 mL of lysis buffer
(50 mM Tris, pH 8.0, 150 mM NaCl, 1% Nonidet-P40, 0.5%
sodium deoxycholate) using liquid nitrogen. Proteins were
extracted after centrifugation for 10 min at 4°C and quantified
using Bradford assay. Protein expression and phosphorylation
were determined byWestern blot as previously described (Zeidan
et al., 2006). Primary antibodies for leptin [anti-leptin antibody
Ob (Y-20), Santa Cruz Biotechnology, CA, USA], p-GATA-4 (Ser
262, Santa Cruz Biotechnology, CA, USA), and GAPDH (Santa
Cruz Biotechnology, CA, USA) were added to the membranes at
1:1000 ratio with 3% BSA for 1 h.
Measurement of G-actin/F-actin Ratio
F-actin and G-actin were extracted and blotted as described
previously (Zeidan et al., 2007). Briefly, RPVs were snap-frozen
and homogenized in F-actin stabilization buffer [50 mmol/L
PIPES, 5 mmol/L MgCl2, 50 mmol/L NaCl, 5 mmol/L EGTA, 5%
(v/v) lyceral, 0.1% (v/v) Triton X-100, 0.1% (v/v) Nonidet P-40,
0.1% (v/v) Tween 20, 0.1% (v/v) 2-mercaptoethanol and 0.001%
(v/v) antifoam and a protease inhibitor cocktail] followed by high
speed centrifugation for 1 h at 100,000 g to separate the G-actin
(supernatants) from F-actin (pellets). In order to depolymerize
the F-actin, the pellets were resuspended in cold cytochalasin D
(1 mmol/L; Calbiochem, CA, USA). Equal amounts of both the
supernatant and the resuspended pellet were subjected toWestern
blot analysis using rabbit polyclonal actin antibody (Cell Signaling
Technology, MA, USA).
Measurement of Protein Synthesis
Rat portal veins were kept in organ culture with the different kinds
of CM for 2 days. RPVs were then cultured for another 24 h with
[3H]-leucine in order to measure protein synthesis as described
previously (Zeidan et al., 2003b).
RNA Isolation and Real-time PCR
RNA was isolated and Real-Time PCR was done as previously
described (Zeidan et al., 2005). The primers were: Nox1
forward 50-TTTCCTAAACTACCGACTC-30 and Nox1
reverse 50-GTGCGACAACGGACTATC-30, Nox2 forward
50-CCCTTTGGTACAGCCAGTGAAGAT-30 and Nox2 reverse
50-CAATCCCAGCTCCCACTAACATCA-30, Nox4 forward
50-GGATCACAGAAGGTCCCTAGCAG-30 and Nox4 reverse
50-GCAGCTACATGCACACCTGAGAA-30, and 18S rRNA
forward 50-GTAACCCGTTGAACCCCATT-30 18S rRNA
reverse 50-CCATCCAATCGGTAGTAGCG-30 which was used as
the housekeeping gene to normalize expression.
ROS Analysis
Reactive oxygen species production in response to mechanical
stretch or leptin was detected by dihydroethidium (DHE) staining
(10mM, Sigma-Aldrich). RPV slices (5mm-thick frozen sections)
were incubated with DHE at 37°C, 5% CO2 for 30 min in
a humidified chamber protected from light. Positive DHE
intensity signals were quantified using a laser confocalmicroscope
(LSM710, ZEN confocal software Carl Zeiss).
Immunohistochemistry
To visualize leptin expression, 5 mm-thick frozen RPV sections
were fixed using 4% formaldehyde and permeabilized using 0.2%
Triton X-100. Nonspecific binding was blocked by 1% BSA, 0.1%
Triton x-100 in PBS for 10 min followed by incubation with
anti-leptin antibody [Ob (Y-20) at 1:100 ratio in 1% BSA and
0.05% Tween in PBS] for 1 h. RPV sections were then washed
and incubated for another hour at room temperature with Alexa
594-conjugated goat anti-mouse secondary antibody (1:250 in
1% BSA and 0.05% Tween in PBS; Molecular Probes). Images
were acquired with a laser confocal microscope (LSM710, ZEN
confocal software Carl Zeiss).
For F-actin and G-actin ratio study, RPV frozen sections were
fixed in 4% formaldehyde, 0.2% Triton x-100 in the cytoskeleton
stabilizing PEM buffer (100 mM PIPES, 5 mM EGTA, 2 mM
MgCl2, pH 6.9) for 20 min at room temperature. Thereafter, the
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sectionswere permeabilized, blocked, and stainedwith the F-actin
stain Phalloidin (100 nM; Acti-stain 555 phalloidin, Cytoskeleton,
Denver, CO, USA) and the G-actin stain Deoxyribonuclease
I (300 nM; Alexa Fluor 488 conjugate, Invitrogen, NY, USA).
All sections were examined and positive intensity signals were
quantified using a laser confocal microscope (LSM710, ZEN
confocal software Carl Zeiss).
Detection of GATA-4 Nuclear Translocation
Rat Aortic Smooth Muscle Cells (RASMC) were cultured at a
concentration of 40 103 per ml in DMEMmedia supplemented
with 10% fetal bovine serum for 72 h and then starved for another
24 h. Leptin (3.1 nmol/L) was added with or without Y-27632
(10mmol/L), cytochalasin D (1mmol/L), or apocynin (1mmol/L).
Cells were then rinsed twice with PBS without Ca2+/Mg2+,
fixed with 4% paraformaldehyde for 10 min, permeabilized with
0.2% Triton X-100 for 20 min, and blocked with 1% BSA, 0.1%
Triton x-100 in PBS for 1 h. Anti-GATA-4 antibody (GATA-4,
Santa Cruz Biotechnology, CA, USA) at 1:100 ratio in 1% BSA,
0.05% Tween in PBS was incubated with the RASMC overnight
at 4ºC, followed by incubation with CruzFluor 488-conjugated
goat anti-mouse secondary antibody (1:250 in 1% BSA and 0.05%
Tween in PBS) in the dark for 1 h. Phalloidin (100 nM; Acti-
stain 555 phalloidin, Cytoskeleton, Denver, CO, USA) was then
added for 20 min to stain actin. Images were acquired using a
laser confocal microscope (LSM710, ZEN confocal software Carl
Zeiss).
Determination of Leptin Release
To determine whethermechanical stretch stimulates leptin release
from VSMCs, culture medium was assayed for leptin protein
by using a TiterZyme enzyme immunometric assay kit (Assay
Designs, Inc., Ann Arbor, MI, USA).
Statistical Analysis
Values for the experimental groups were normalized to the
unstretched RPVs. Data values are presented as mean standard
error of the mean (SEM). Statistical data was analyzed using t-
test or one-way analysis of variance (ANOVA), and significance
was established by Holm-Sidak or Tukey methods. Statistical
significance was considered for p<0.05 between groups.
RESULTS
Mechanical Stretch/hypertension
Increases the Intracellular Leptin Protein
Levels in VSMCs
We have shown previously the ability of mechanical stretch to
induce leptin secretion into culture media after 1–3 days of
stretching (Zeidan et al., 2005). In this study, we investigated the
effect of mechanical stretch on the endogenous leptin expression
level inVSMCs. RPVswere cultured for 1 h or 24 hwith orwithout
stretch.
The effect of mechanical stretch on leptin expression in
VSMCs was first analyzed using a laser confocal microscope
(LSM710, ZEN confocal software, Carl Zeiss). Figures 1A,B
show that intracellular leptin levels were significantly increased
after 1 and 24 h of mechanical stretch. These findings indicate
that mechanical stretch has the ability to induce leptin protein
synthesis at early (1 h) and late stages (24 h). In agreement
with the previous study of immunohistochemistry, Western blot
analysis of protein lysates prepared from the RPVs revealed that
intracellular leptin expression was significantly increased after 1 h
of mechanical stretch by fourfold and after 24 h of stretch by 2.5
fold (Figure 1C).
To explore the role of mechanical stretch-induced leptin
expression on leptin release from VSMCs into the culture
medium, we examined the effect of mechanical stretch for 1,
3, 6, 18, and 24 h on leptin release using an immunometric
assay. Figure 1D shows that stretching RPVs for 3, 6, 18, or
24 h significantly induced leptin release into the culture medium.
These results indicate the direct effect of mechanical stretch on
both leptin synthesis and release.
Role of Endogenous Leptin in Mediating
Stretch-induced Hypertrophy
We tested the hypertrophic effect of CM taken from RPVs
unstretched or stretched for 24 h. The CM removed from
unstretched RPVs [CM (Unst 24 h)] had no effect on wet weight
or protein synthesis of RPVs cultured for 3 days with the CM
(Figures 2A,B). However, CM taken from stretched RPVs [CM
(St 24 h)] significantly increased RPV wet weight (Figure 2A) as
well as protein synthesis (Figure 2B). We also determined the
relationship between wet and dry RPV weights in control and
hypertrophied strips (data not shown); there were no significant
differences in the dry weight/wet weight ratios in different groups,
indicating that increased tissue weights were not due to increased
water retention.
To ascertain whether CM-induced hypertrophy was mediated
by leptin, RPVs were cultured for 3 days with anti-leptin antibody
(1 mmol/L) and CM taken from stretched RPVs for 24 h [CM
(St 24 h) + Anti-Lep]. As shown in Figures 2A,B, treatment
with anti-leptin antibody significantly attenuated CM-induced
increase in tissue weight and protein synthesis, suggesting that the
hypertrophic effect of CM is mediated, at least in part, by leptin in
CM.
Mechanical Stretch- and Leptin-induced
Actin Cytoskeleton Remodeling
Since hypertrophy is characterized by remodeling of the actin
cytoskeleton, Western blot analysis was performed for G-actin
and F-actin in order to study the effect of mechanical stretch on
hypertrophy. RPVs were mechanically stretched for 24 h, and the
ratio of F-actin to G-actin was calculated and normalized to the
unstretched (control) RPVs (Figure 3A). The F/G-actin ratio for
the stretched RPVs was significantly greater (approximately 5.6
fold) than that for the control RPVs (Figure 3A), indicating that
the levels of F-actin had increased significantly relative to those of
G-actin, a main indicator of hypertrophy (Figure 3).
Rat portal veins were treated with leptin at a concentration
of 3.1 nmol/L (50 ng/mL) due to its equivalence to leptin
concentrations in obesity (Maffei et al., 1995; Rajapurohitam
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FIGURE 1 | Mechanical stretch-induced intracellular leptin protein expression and secretion. RPVs were subjected to stretch for 1 or 24 h (A).
Representative confocal microscopic images for leptin detection in RPV wall after stretching for 1 or 24 h. DAPI stained the nuclei blue, while leptin primary antibody
was visualized by Alexa 594-conjugated secondary antibody (red). (B). Fluorescence intensity measurements of leptin protein detected by immunohistochemistry.
(C). Expression of leptin protein was evaluated using Western blotting densitometric scans and normalized to the unstretched RPVs. (n=5–9). Stretch for 1 h
significantly increased intracellular leptin expression, more than stretch for 24 h. (D). Leptin release into the extracellular media was measured using ELISA for
mechanically stretched RPVs for 1, 3, 6, 18, or 24 h. Leptin release significantly increased after 3–24 h of stretch. *p < 0.05 versus unstretched (Unst). #p < 0.05
versus stretched 1 h (St 1 h).
FIGURE 2 | Mechanical stretch-induced VSMC hypertrophy is mediated by leptin protein release. Effect of different kinds of conditioned media (CM)
prepared from either media alone (M), from unstretched (Unst) RPVs’ media (Unst 24 h), from stretched RPVs’ media (St 24 h), or CM from stretched RPVs with
anti-leptin antibody [CM(St 24 h) + Anti-Lep] on tissue wet weight (A) and [3H]-leucine incorporation (B) in RPVs cultured for 3 days. *p < 0.05 versus unstretched
(Unst). (n=6–9). #p < 0.05 versus stretched 24 h (St 24 h).
et al., 2003; Zeidan et al., 2005) for 24 h and the ratio of F/G-
actin was calculated and normalized to unstretched (untreated)
RPVs (Figure 3D). Similarly to the effect of mechanical stretch,
treatment with leptin resulted in a significant increase in F/G-
actin ratio (approximately 1.5 fold), indicating that leptin alone
indeed promotes vascular remodeling in the form of hypertrophy.
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FIGURE 3 | Mechanical stretch- and leptin- induced actin cytoskeleton dynamics. RPVs were cultured for 24 h under mechanical stretch (A–C) or treated
with 3.1 nmol/L leptin (D–F). F- and G-actin were separated by ultracentrifuge followed by Western blot of pellets (F-actin; F) and supernatants (G-actin; G). (n=5).
*p < 0.05 versus unstretched (Unst). Representative confocal microscopic images for RPV wall stained with the G-actin stain Deoxyribonuclease I (B,E); (left panels;
green) and the F-actin stain Acti-stain 555 phalloidin (B,E); (middle panels; red). The overlay of both F- and G- actin (merged) is shown in the right panels (B,E).
(n=3). Quantification of Phalloidin and Deoxyribonuclease I positive areas indicate that mechanical stretch (C) or leptin (F) for 24 h resulted in a decrease in G-actin
levels and increase in F-actin levels.
FIGURE 4 | Mechanical stretch-induced ROS production. (A). Representative confocal microscopic images of RPV wall stained with DHE. (B). Fluorescence
intensity measurements of DHE positive area of the mechanically stretched RPVs for 1 or 24 h (n=4). *p < 0.05 versus unstretched (0 h).
The effect of mechanical stretch and leptin on actin
cytoskeleton remodeling of RPVs was also analyzed by confocal
microscopy using Phalloidin and Deoxyribonuclease I to stain
F-actin and G-actin, respectively. Stretching RPVs or treating
with leptin for 24 h significantly lowered G-actin levels and
increased F-actin compared to the controls (Figures 3B,C,E,F),
consistent with the Western blot findings.
Mechanical Stretch Induces ROS
Production in VSMCs
Figure 4A shows that the DHE fluorescence level (red fluorescent
signal; ROS) in the unstretched RPV (control) was low while the
DHE fluorescence intensity significantly increased after 1 and 24 h
of mechanical stretch (six- and fourfolds, respectively) compared
to unstretched RPV (Figures 4A,B).
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FIGURE 5 | Mechanical stretch-induced Nox expression. Effect of mechanical stretch on the mRNA expression of Nox1, Nox2, and Nox4. (n=8–10). *p < 0.05
versus control (0 h).
FIGURE 6 | Role of the RhoA/ROCK pathway in leptin- / mechanical stretch-induced ROS formation. Effect of Y-27632 (Y; 10 mmol/L) or cytochalasin D
(Cyto D; 1 mmol/L) on mechanical stretch- (A) and leptin- (E) induced ROS formation. (C). Effect of inhibition of leptin by anti-leptin antibody (Anti-Lep) on mechanical
stretch-induced ROS formation. Fluorescence intensity measurements of DHE positive area of the mechanically stretched (B,D) and leptin-induced (F) RPVs treated
with Anti-Lep, Y, or Cyto D (n=3). *p < 0.05 versus unstretched (Unst). #p < 0.05 versus stretched 1 hr (St 1 h).
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Accumulating evidence suggests that NADPH oxidase (Nox)
activity and expression have an important role in ROS formation
in various cells types including VSMCs (Clempus and Griendling,
2006; Lyle and Griendling, 2006). To investigate the effect of
mechanical stretch on Nox expression, RPVs were stretched
for 1, 3, 6, 18, or 24 h and the mRNA expressions of Nox1,
Nox2, and Nox4 were analyzed using qPCR. Nox1 and Nox4
mRNA expressions were increased after mechanical stretch, while
Nox2 mRNA expression was not affected by mechanical stretch
(Figure 5). These data indicate that Nox1 and Nox4 may be
important in producing ROS after 24 h of stretch, but perhaps not
so much after 1 h. On another hand, Nox2 expression had no role
in mediating mechanical stretch-induced ROS formation.
ROS Formation is Mediated by Leptin and
the RhoA Pathway
To gain insight into the mechanism underlying the mechanical
stretch-induced increase in ROS production, stretched RPVs for
1 h were pretreated with the ROCK inhibitor Y-27632 compound
(10mmol/L) and the actin depolymerization agent cytochalasin D
(1mmol/L). DHE fluorescence revealed that treatment with either
Y-27632 compound or cytochalasin D significantly decreased
mechanical stretch-induced ROS formation (Figures 6A,B),
suggesting the involvement of the RhoA/ROCK pathway and the
importance of an intact cytoskeleton in the production of ROS
induced by mechanical stretch.
To investigate whether leptin synthesis is involved in
mechanical stretch-induced ROS formation, RPVs were
pretreated anti-leptin antibody for 1 h followed by mechanical
stretch for 1 h. Figures 6C,D show that anti-leptin antibody
significantly prevented mechanical stretch-induced ROS
production, indicating the significant role of leptin in mechanical
stretch-induced ROS generation.
To gain more information about the effect of exogenous
leptin on ROS formation, RPVs were treated with 3.1 nmol/L
leptin for 1 h, equivalent to leptin concentrations in obesity.
Figures 6E,F shows that leptin treatment significantly increased
ROS formation, whereas pretreatment with Y-27632 or
cytochalasin D significantly attenuated leptin-induced ROS
production. These data show the involvement of Rho/ROCK
pathway and intact actin cytoskeleton in leptin-induced ROS
formation.
We also assessed whether Y-27632 and cytochalasin D could
prevent the mechanical stretch-induced upregulation of Nox1
and Nox4 mRNA expression using qPCR analysis after 6 and
24 h, respectively (the peaks of mRNA upregulation). Figure 7
shows that upregulation ofNox1 andNox4 induced bymechanical
stretch was attenuated when RPVs were pre-treated with Y-27632
or cytochalasin D, indicating the involvement of ROCK activation
and an intact actin cytoskeleton in mechanical stretch-induced
Nox1 and Nox4 overexpressions.
Leptin Induces GATA-4 Phosphorylation
and Nuclear Translocation
GATA-4 is a transcription factor that translocates from the
cytoplasm to the nucleus upon activation, and in turn upregulates
hypertrophic gene expression. To study whether the hypertrophic
effect of leptin was mediated by GATA-4 phosphorylation
and nuclear translocation, RASMC were treated with leptin
(3.1 nmol/L) for 15, 30, and 60 min, followed by Western blotting
or immunostaining to mark GATA-4 proteins. Figures 8A,B
shows that GATA-4 phosphorylation and nuclear translocation
were markedly increased by 30 and 60 min of leptin treatment.
Thus, leptin mediates vascular remodeling, at least in part, by a
GATA-4-dependent mechanism.
GATA-4 Nuclear Translocation is
Dependent on the RhoA/ROCK Pathway
and an Intact Cytoskeleton
To examine whether the RhoA/ROCK pathway is involved
in mediating GATA-4 nuclear translocation in response to
leptin, RASMC were pre-treated with Y-27632 (10 mmol/L)
or cytochalasin D (1 mmol/L) followed by leptin treatment
for 60 min. GATA-4 nuclear translocation was noticeably
abolished by treatment with either Y-27632 or cytochalasin D
(Figure 9), indicating that the RhoA/ROCKpathway and an intact
cytoskeleton are crucial for leptin-induced GATA-4 translocation
to the nucleus.
ROS Depletion Inhibits GATA-4 Nuclear
Translocation
To study whether there is an interaction between ROS and GATA-
4, the Nox inhibitor apocynin (1 mmol/L) was added to RASMC
to deplete ROS, followed by leptin treatment. RASMC treatedwith
apocynin and leptin for 60 min exhibited a marked reduction in
GATA-4 nuclear translocation compared to leptin-treated cells
alone (Figure 10), indicating that ROS are upstream to GATA-4
translocation.
DISCUSSION
Understanding the molecular mechanisms involved in
cardiovascular disease during obesity and hypertension is
crucial in order to identify novel therapeutic targets for treating
their associated-vascular and cardiac disorders. Obesity is
associated with high levels of the circulating hormone leptin
(hyperleptinemia), which in turn is responsible for several
cardiovascular diseases. The exact mechanism(s) by which
leptin is associated with hypertension and the progression of
cardiovascular diseases remains to be investigated as discussed in
this work.
The major findings in the present study include: (1)
Identification of a direct effect of the mechanical stretch
model (mimicking hypertension) on endogenous leptin
synthesis in VSMCs. (2) Involvement of Nox1 and Nox4
but not Nox2 expression in mechanical stretch-induced ROS
formation in VSMCs. (3) Leptin induces ROS formation in
VSMCs, in a RhoA/ROCK-dependent manner. (4) Leptin
induces GATA-4 phosphorylation and nuclear translocation
through the RhoA/ROCK pathway and ROS, as summarized in
Figure 11.
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FIGURE 7 | Role of the RhoA/ROCK pathway and intact cytoskeleton on Nox expression. Effect of Y-27632 (Y; 10 mmol/L) or cytochalasin D (Cyto D;
1 mmol/L) on mechanical stretch-induced Nox1 and Nox4 gene expression using qPCR analysis. (n=8–10). *p < 0.05 versus unstretched. #p < 0.05 versus
stretched.
FIGURE 8 | Leptin-induced GATA-4 phosphorylation and nuclear translocation. RASMC were treated with leptin (3.1 nmol/L) for 15, 30, and 60 min followed
by Western blotting (A) or laser confocal microscopic analysis (B) for GATA-4 detection. Protein lysates were immunoblotted using anti-p-GATA-4 antibody to detect
GATA-4 phosphorylation using Western blot (A). For immunostaining to detect GATA-4 translocation to the nucleus, GATA-4 antibody was visualized by CruzFluor
488-conjugated secondary antibody (second panel; green). Acti-stain 555 phalloidin stained F-actin (third panel; red), while DAPI stained the nuclei blue (first panel;
blue). The overlay of DAPI, GATA-4, and F-actin (merged) is shown in the right panel.
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FIGURE 9 | Role of the RhoA/ROCK pathway in leptin-induced GATA-4
translocation. Representative confocal microscopic images of RASMC to
study the effect of Y-27632 (Y; 10 mmol/L) or cytochalasin D (Cyto D;
1 mmol/L) on leptin-induced GATA-4 translocation. DAPI stained the nuclei
(left panel; blue) and GATA-4 was detected using CruzFluor 488-conjugated
secondary antibody (middle panel; green). The overlay (merged) is shown in
the right panel. GATA-4 translocation in response to leptin was abolished by Y
and Cyto D.
Rat portal vein organ culture was used in this study to evaluate
the effect of mechanical stretch on vascular remodeling. This ex-
vivo model was used since it has been well-characterized in a
number of recent publications related to the hypertrophic effect of
mechanical stretch (Zeidan et al., 2000, 2003a,b, 2004, 2005; Ren
et al., 2010; Turczynska et al., 2012, 2013).
Because of its myogenic vasomotion, the RPV has been
used in the development of vasoactive drugs as an analog of
small pre-capillary resistance vessels (Ljung, 1990). Moreover,
the longitudinally oriented musculature in the RPV makes it
an ideal blood vessel for investigating the effect of mechanical
stress on muscle hypertrophy by stretching it by weight loading
rather than perfusion. In addition, mechanical stretch maintained
the differentiated status of the VSMCs in this ex-vivo model as
evidenced by amarked increase in SM22 synthesis (differentiation
marker forVSMCs) andmuscle contractility, unlikeVSMCs in cell
culture (Zeidan et al., 2003b). Moreover, the effect of increased
RPV pressure (in vivo) due to partial occlusion in the portal
vein has been implicated in VSMC hypertrophy (Malmqvist and
Arner, 1988, 1990). Many signaling complexes act as sensors
and transducers of mechanical stretch such as growth factors,
ROS, nuclear factor kappaB, and Na+/H+ exchanger isoform
1 (Dzau, 1993; Koller, 2002; Lemarie et al., 2006; Paravicini
and Touyz, 2006; Haga et al., 2007). We have previously shown
that mechanical stretch stimulated VSMC hypertrophy via the
activation of MAPK pathways, RhoA/ROCK pathways, and actin
cytoskeleton remodeling (Zeidan et al., 2000, 2003a,b, 2004,
2005).
Many studies have shown a clear relationship between plasma
leptin levels and hypertension in different animal models
(Hiraoka et al., 1997; reviewed, by Stenvinkel, 2000) and in
humans (Agata et al., 1997; Uckaya et al., 1999). However, the
mechanism by which hypertension increases plasma leptin levels
is still not clear. Plasma levels of leptin, in general, are higher in
essential hypertensive patients (not obese) compared to controls
(Agata et al., 1997; Uckaya et al., 1999). Indeed, we have previously
found that mechanical stretch enhances the release of leptin from
VSMCs to culture media and increases leptin mRNA expression
after 1, 2, and 3 days of stretching along with vascular remodeling
(Zeidan et al., 2005).
The current study sought to delineate the possible role of
increased mechanical stretch (hypertension) on leptin protein
synthesis in VSMCs and on early time points of leptin release
(1, 3, 6, 18 h). Interestingly, we have found that significant
alterations in leptin protein expression occurred after only 1 h of
mechanical stretch coupled with lower intracellular leptin levels
24 h post mechanical stretch. The hypothesis for this decrease
in the intracellular leptin levels after 24 h is that leptin was
secreted outside the VSMCs and that the biosynthesis of leptin
itself was downregulated; the underlying mechanism needs to be
further investigated. However, these data highlighted the critical
role of leptin in mechanical stretch induced-VSMC hypertrophy
as discussed in previous findings from our lab (Zeidan et al.,
2003a).
To further validate the above findings, CM taken from stretched
RPVs was shown to induce RPV hypertrophy while CM from
unstretched RPVs had no effect on RPV hypertrophy, indicating
the presence of hypertrophic related-protein(s) in CM as shown
in Figure 2. Adding the anti-leptin antibody to CM taken
from stretched RPVs inhibited the hypertrophic effect of CM,
indicating the important role of secreted leptin in mediating CM-
induced RPV hypertrophy.
As for the dynamics of actin cytoskeleton, our work shows that
mechanical stretch increases actin polymerization as reflected by
an increase in the F-actin to G-actin ratio by 5.6 fold, while leptin
increases it by 1.5 fold (Figure 4). The reported results are in
line with the idea that leptin decreases the levels of G-actin with
respect to F-actin via the RhoA/ROCK/p-cofilin pathway.
Among the aims of this study was to investigate the role of ROS
formation inmechanical stretch-inducedVSMCremodeling. ROS
has several implications on cardiovascular functions (Zafari et al.,
1998; Touyz and Schiffrin, 1999), including vascular remodeling.
In this study, ROS formation was upregulated 1 h post mechanical
stretch. Of interest, treating RPVswith exogenous leptin exhibited
similar results to mechanical stretch, while inhibiting leptin
synthesis in turn inhibited mechanical stretch-induced ROS
formation. These data indicate that ROS formation is induced
through leptin synthesis as shown in Figure 6. Taken together, our
data strongly suggest the important pathophysiological roles of
hypertension and hyperleptinemia for increased ROS production
in VSMCs.
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FIGURE 10 | Involvement of ROS in leptin-mediated GATA-4 nuclear translocation. Effect of the NADPH oxidase inhibitor apocynin (1 mmol/L) on
leptin-induced GATA-4 nuclear translocation in RASMC. GATA-4 antibody was visualized by CruzFluor 488-conjugated secondary antibody (second panel; green)
while Acti-stain 555 phalloidin was used to stain F-actin (third panel; red). DAPI stained the nuclei blue (first panel; blue). The overlay of DAPI, GATA-4, and F-actin
(merged) is shown in the right panel. ROS depletion inhibited GATA-4 nuclear translocation.
Moreover, this study shows a link between ROS production
and the RhoA/ROCK pathway activation. ROCK inhibition and
depolymerization of the actin cytoskeleton significantly lowered
both leptin-/mechanical stretch-induced ROS formation, thereby
placing ROS formation downstream to RhoA/ROCK (Figure 6).
Moreover, we analyzed the effect of mechanical stretch on
the expression pattern of different NADPH oxidases (Nox1,
Nox2, Nox4). Mechanical stretch upregulated Nox1 and Nox4
expressions but not Nox2, indicating the important role of Nox1
and Nox4 in mechanical stretch/hypertension-induced vascular
remodeling. Nox1 expression increased significantly after 1 h of
mechanical stretch and remained high throughout until 24 h,
indicating that Nox1 is perhaps an early response NADPH
oxidase to stretch (Szöcs et al., 2002). Nox4 expression increased
significantly after 18 h of stretch, suggesting that it is responsible
for the late (24 h) production of ROS in response to stretch.
Given these time points, we concluded that Nox1 and Nox4 are
responsible for generating ROS in response to 24 h of stretch, but
not at 1 h of stretch. Nox2 expression did not change in response to
stretch and thus not responsible for the increase in ROS formation
after stretch. It is interesting to note that a recent study by Byrne
et al. reported that Nox2 expression and activation is not critical
for pressure overload-induced cardiac hypertrophy (Byrne et al.,
2003; Maytin et al., 2004). Moreover, the importance of Nox4
has been shown in pressure overload-induced left ventricular
hypertrophy (Byrne et al., 2003). Our results have shown that
Nox1 and Nox4 upregulation was attenuated by both ROCK
inhibitor and actin depolarization agent, further suggesting an
important role for the RhoA/ROCK pathway in downstream ROS
formation.
Increased wall tension results in hypertrophy, which begins
as a compensatory response, but is actually detrimental. The
role of GATA-4 in promoting in hypertrophy has been well
established in the cardiac system, since it is a transcription
factor that activates hypertrophic gene expression like b-MHC,
c-fos, c-jun, c-myc, BNP, and ANF (Chien et al., 1991; Liang
and Gardner, 1999; Saadane et al., 1999; Babu et al., 2000). We
already know that leptin induces VSMC hypertrophy (Zeidan
et al., 2005), and this current study reveals a mechanism of
leptin-induced VSMC hypertrophy (Figure 3). Furthermore, our
present data indicate that leptin promotes the phosphorylation
and nuclear translocation of GATA-4, and that this leptin-
induced GATA-4 activation is inhibited by the ROCK inhibitor
and actin depolymerization agent (Y-27632 and cytochalasin D
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FIGURE 11 | Proposed scheme for mechanical stretch-induced VSMC hypertrophy through leptin synthesis, RhoA/ROCK pathway, ROS formation,
and GATA-4 nuclear translocation. Please see Discussion for description.
respectively). Since leptin and the RhoA/ROCK pathway are
implicated in VSMC hypertrophy (Yamakawa et al., 2000; Zeidan
et al., 2005), we believe that GATA-4 activation and translocation
plays a hypertrophic role in the vascular system as shown by these
new findings. Moreover, the role of GATA-4 has been linked in
the vascular system by regulating cardiac angiogenesis (Heineke
et al., 2007) and embryonic angiogenesis in the vascular plexus
(Torregroza et al., 2012). The contribution of ROS to GATA-4
activation in response to leptin has been studied. The NAPDH
oxidase inhibitor apocynin was used to inhibit ROS formation
(Pi et al., 2013; Schroeter et al., 2013), followed by analysis of
GATA-4 nuclear translocation. ROSdepletionmarkedly abolished
GATA-4 nuclear translocation in response to leptin. Therefore,
these data indicate that ROS may activate GATA-4 and induce
GATA-4 nuclear translocation.
In conclusion, this study highlighted the molecular
mechanisms involved in mechanical stretch-induced VSMC
hypertrophy and the critical involvement of endogenous leptin,
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ROS formation, and GATA-4 nuclear translocation. Based on
our findings in this study, we were able to construct a putative
pathway of the mechanism mediating the above changes of
mechanical stretch/leptin cross-talk as depicted in Figure 11.
As shown, mechanical stretch acts as an upstream regulator of
ROS formation and GATA-4 nuclear translocation through leptin
synthesis, RhoA/ROCK activation, and F/G-actin ratio changes
(please refer to Figures 1, 3, 4, and 6)
Further research should be done in order to provide a
more detailed picture of the mechanisms of action. The
links between the different signal transducers may provide a
helpful approach in developing potential therapeutic strategies
to attenuate the harmful effects of hypertension and leptin on
vascular remodeling.
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